View Filing Data

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2014	Oct. 31, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	Semler Scientific, Inc.
Entity Central Index Key	0001554859
Trading Symbol	smlr
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		4,709,217
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Amendment Flag	false
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]
Revenue	$ 897	$ 589	$ 2,580	$ 1,493
Operating expenses:
Cost of revenue	178	133	504	276
Engineering and product development	262	60	906	254
Sales and marketing	1,040	569	2,514	1,585
General and administrative	784	324	1,821	1,003
Total operating expenses	2,264	1,086	5,745	3,118
Loss from operations	(1,367)	(497)	(3,165)	(1,625)
Other expense:
Interest expense	(100)	(27)	(152)	(83)
Other income	1	1	2	1
Other expense	(99)	(26)	(150)	(82)
Loss before income tax expense	(1,466)	(523)	(3,315)	(1,707)
Income tax expense
Net loss	$ (1,466)	$ (523)	$ (3,315)	$ (1,707)
Net loss per share, basic and diluted (in dollars per share)	$ (0.31)	$ (0.66)	$ (0.85)	$ (2.17)
Weighted average number of shares used in computing basic and diluted loss per share (in shares)	4,708,162	786,750	3,900,746	786,750

Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Current Assets:
Cash	$ 5,973	$ 734
Trade accounts receivable, net of allowance for doubtful accounts of $31 and $15, respectively	311	228
Prepaid expenses and other current assets	168	47
Total current assets	6,452	1,009
Assets for lease, net	696	512
Property and equipment, net	6	1
Deferred financing costs	73	202
Total assets	7,227	1,724
Current liabilities:
Accounts payable	217	255
Accrued expenses	1,472	1,128
Deferred revenue	805	366
Equipment on lease, current portion		47
Loans payable, current portion	113	60
Total current liabilities	2,607	1,856
Long-term liabilities:
Equipment on lease, net of current portion		65
Loans payable, net of current portion		98
Total long-term liabilities		163
Stockholders' equity (deficit):
Common stock, $0.001 par value; 50,000,000 shares authorized; 4,734,217 and 811,750 shares issued, and 4,709,217 and 786,750 outstanding (net of treasury shares of 25,000 and 25,000), respectively	5	1
Additional paid-in capital	17,282	2,346
Accumulated deficit	(12,667)	(9,352)
Total stockholders' equity (deficit)	4,620	(295)
Total liabilities and stockholders' equity (deficit)	7,227	1,724
Series A Preferred Stock
Stockholders' equity (deficit):
Convertible preferred stock		6,020
Series A-1 Preferred Stock
Stockholders' equity (deficit):
Convertible preferred stock		482
Series A-2 Preferred Stock
Stockholders' equity (deficit):
Convertible preferred stock		$ 208

Condensed Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Allowance for doubtful accounts on trade accounts receivable (in dollars)	$ 31	$ 15
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	4,734,217	811,750
Common stock, shares outstanding	4,709,217	786,750
Treasury stock, shares	25,000	25,000
Series A Preferred Stock
Convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	2,800,000	2,800,000
Convertible preferred stock, shares issued	0	1,468,402
Convertible preferred stock, shares outstanding	0	1,468,402
Convertible preferred stock, liquidation preference (in dollars)	$ 0	$ 6,608
Series A-1 Preferred Stock
Convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	800,000	800,000
Convertible preferred stock, shares issued	0	293,750
Convertible preferred stock, shares outstanding	0	293,750
Convertible preferred stock, liquidation preference (in dollars)	$ 0	$ 1,175
Series A-2 Preferred Stock
Convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	400,000	400,000
Convertible preferred stock, shares issued	0	250,000
Convertible preferred stock, shares outstanding	0	250,000
Convertible preferred stock, liquidation preference (in dollars)	$ 0	$ 500

Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,315)	$ (1,707)
Reconciliation of Net Loss to Net Cash Used in Operating Activities:
Amortization of deferred financing costs	129	66
Depreciation	140	86
Loss on disposal of assets for lease	67	44
Allowance for doubtful accounts	104	48
Stock-based compensation expense	178	141
Changes in Operating Assets and Liabilities:
Trade accounts receivable	(186)	(180)
Prepaid expenses and other current assets	(122)	(5)
Accounts payable	(39)	142
Accrued expenses	345	182
Deferred revenue	439	298
Net Cash Used in Operating Activities	(2,260)	(885)
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property and equipment	(5)
Purchase of assets for lease	(391)	(192)
Net Cash Used in Investing Activities	(396)	(192)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock	10,010
Issuance of convertible preferred stock		2,409
Offering costs	(1,959)	(482)
Payments of loans payable	(45)	(45)
Payments of equipment leases	(111)	(32)
Net Cash Provided by Financing Activities	7,895	1,850
INCREASE (DECREASE) IN CASH	5,239	773
CASH, BEGINNING OF PERIOD	734	731
CASH, END OF PERIOD	5,973	1,504
Cash paid for interest	23	$ 17
Supplemental disclosure of noncash financing activity:
Conversion of preferred stock into common stock	$ 6,707

Basis of Presentation

9 Months Ended

Sep. 30, 2014

Basis Of Presentation [Abstract]

Basis of Presentation

Basis of Presentation

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the prospectus filed with the SEC pursuant to Rule 424(b) on February 21, 2014 (the “Prospectus”). The balance sheet as of December 31, 2013 included in this report has been derived from the audited financial statements included in the Prospectus. In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year. Items in prior year financial statements have been adjusted to conform with the current year presentation.

Initial Public Offering

In February 2014, the Company completed its initial public offering (“IPO”) in which it issued and sold 1,430,000 shares of its common stock at a public offering price of $7.00 per share. The Company received net proceeds of $7,403 after deducting underwriting discounts and commissions of $848 and other offering expenses of approximately $1,759. The Company incurred $648 of the offering expenses in 2013, and incurred $1,959 of such expenses in the first quarter of 2014. The Company granted the underwriter an overallotment option to acquire an additional 214,500 shares of its common stock, which expired April 6, 2014 unexercised, and issued the underwriter warrants to acquire an aggregate of 71,500 shares of its common stock at an exercise price of $8.75 per share, which become exercisable February 20, 2015 and expire February 20, 2019. Upon the closing of the IPO, all shares of the Company’s then-outstanding Series A convertible Preferred Stock (1,468,402), Series A-1 convertible Preferred Stock (293,750) and Series A-2 convertible Preferred Stock (250,000) automatically converted into an aggregate of 2,012,152 shares of common stock. In addition, the Company’s then outstanding warrants to acquire an aggregate of 1,067,210 shares of Series A convertible Preferred Stock and 228,656 shares of Series A-1 convertible Preferred Stock were cashlessly exercised at the IPO price for an aggregate of 479,115 shares of common stock. All other outstanding warrants of the Company became exercisable for common stock effective upon the IPO in accordance with their terms.

Assets for Lease

9 Months Ended

Sep. 30, 2014

Leases, Capital [Abstract]

Assets for Lease

Assets for Lease

Assets for lease consist of the following:

	September 30, 2014			December 31, 2013

Assets for lease	$	943		$	688
Less: Accumulated Depreciation		(247	)		(176	)
Assets for lease, net	$	696		$	512

Depreciation expense amounted to $48 and $35 for the three months ended September 30, 2014 and September 30, 2013, respectively, and to $140 and $86 for the nine months ended September 30, 2014 and September 30, 2013, respectively. Reduction to accumulated depreciation for returned items was $21 and $21 for the three months ended September 30, 2014 and September 30, 2013, respectively. Reduction to accumulated depreciation for returned items was $69 and $27 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

Deferred Financing Costs

9 Months Ended

Sep. 30, 2014

Deferred Finance Costs [Abstract]

Deferred Financing Costs

Deferred Financing Costs

As of September 30, 2014 and December 31, 2013, deferred financing costs have the gross amounts of $73 and $202, respectively. The amounts amortized to interest expense were $85 and $22 for the three months ended September 30, 2014 and September 30, 2013, respectively. The amounts amortized to interest expense were $129 and $66 for the nine months ended September 30, 2014 and September 30, 2013, respectively. Per details in Note 5, leases were paid off early due to the opening of a new line of credit, resulting in acceleration of the expensing of the outstanding deferred financing costs.

Accrued Expenses

9 Months Ended

Sep. 30, 2014

Accrued Liabilities, Current [Abstract]

Accrued Expenses

Accrued Expenses

Accrued expenses consist of the following:

	September 30, 2014		December 31, 2013

Offering Costs	$	497	$	722
Compensation		589		264
Miscellaneous Accruals		386		142
Total Accrued Expenses	$	1,472	$	1,128

The accumulated offering costs that were accrued pertain to consultant’s fees associated with securing equity financing for the Company.

Commitments and Contingencies

9 Months Ended

Sep. 30, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Loan Financing Arrangements:

On February 9, 2011, the Company entered into an Equipment Finance Agreement with U.S. Bancorp Business Equipment Finance Group. Pursuant to the agreement, the Company obtained a $39 secured loan for a 48-month term that had an annual fixed interest rate of 13%. The loan was secured by the related leased equipment. Under the agreement, the Company made monthly payments consisting of $1 of principal plus any accrued interest. The agreement provided for customary events of default. This loan was personally guaranteed by a Company director and a principal stockholder of the Company. As of September 30, 2014, the Company has retired this facility. At December 31, 2013, the Company had outstanding borrowings of $13.

On May 27, 2011, the Company entered into an Equipment Finance Agreement with U.S. Bancorp Business Equipment Finance Group. Pursuant to the Agreement, the Company obtained a $109 secured loan for a 60-month term that had an annual fixed interest rate of 6%. The loan was secured by the related leased equipment. Under the Agreement, the Company made monthly payments consisting of $2 of principal plus any accrued interest. The Agreement provided for customary events of default. This loan was personally guaranteed by a Company director and a principal stockholder of the Company. As of September 30, 2014, the Company has retired this facility. At December 31, 2013, the Company had outstanding borrowings of $57.

At various dates in 2011, the Company entered into Lease Agreements with Lease Corporation of America. Pursuant to these agreements, the Company obtained an aggregate amount of $66 for a 60-month term that had variable annual interest rates of approximately 14%. The leases were secured by the related leased equipment. Under the agreements, the Company made monthly payments of approximately $1 of principal plus any accrued interest. The agreements provided for customary events of default. The leases were personally guaranteed by a principal stockholder of the Company. As of September 30, 2014, the Company has retired this facility. At December 31, 2013, the Company had outstanding borrowings of $42.

On June 17, 2011, the Company entered into a loan agreement with First Republic Bank. Pursuant to the loan agreement, the Company obtained a $150 secured loan for a 60-month term that had a variable interest rate based on First Republic’s Prime plus a spread of 1.75% p.a. and a floor of 3.25% p.a. The initial interest rate was 5% p.a. Under the loan agreement, the Company made monthly payments consisting of $3 of principal plus any accrued interest. The loan agreement provided for customary events of default. This loan was personally guaranteed by a principal stockholder of the Company. As of September 30, 2014, the Company has retired this loan agreement. At December 31, 2013, the Company had outstanding borrowings of $75.

On September 13, 2011, the Company entered into an additional loan agreement with First Republic Bank. Pursuant to the loan agreement, the Company obtained a $150 loan for a 60-month term that had a variable annual interest rate based on First Republic’s Prime plus a spread of 1.75% and a floor of 3.25%. The initial interest rate was 5%. Under the loan agreement, the Company made monthly payments consisting of $3 of principal plus any accrued interest. The loan agreement provided for customary events of default. This loan was personally guaranteed by a principal stockholder of the Company. As of September 30, 2014, the Company has retired this loan agreement. At December 31, 2013, the Company had outstanding borrowings of $83.

On September 30, 2014, the Company entered into a revolving line of credit with First Republic Bank. Pursuant to the line of credit agreement, the Company may borrow up to $2,000 for a 12-month term that has a variable annual interest rate based on First Republic’s Prime less a spread of 2.0% p.a. The initial interest rate is 1.25% p.a. Under the line of credit agreement, the Company will make monthly payments consisting of $2 of interest, and an annual payment consisting of $2,002 principal plus any accrued interest. The line of credit agreement provides for customary events of default. This line of credit is secured by a collateral cash account in the Company’s name at First Republic. As of September 30, 2014, the Company was in compliance with the material terms of this facility. At September 30, 2014, the Company had outstanding borrowings of $113. Subsequent to the close of the quarter, the Company drew down on the remaining balance of this facility.

Net Loss Per Common Share

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Net Loss Per Common Share

Net Loss Per Common Share

Because the Company was in a loss position for each of the periods presented, diluted net loss per share is the same as basic net loss per share for each period as the inclusion of all potential common shares outstanding would have been anti-dilutive. The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:

	Three Months ended September 30,
	2014		2013
Weighted average shares outstanding:
Convertible preferred stock		-		1,480,042
Convertible preferred stock warrants		-		1,285,838
Common stock warrants		359,714		-
Options		389,663		337,500
Total		749,377		3,103,380

	Nine Months ended September 30,
	2014		2013
Weighted average shares outstanding:
Convertible preferred stock		414,267		1,480,042
Convertible preferred stock warrants		326,134		1,285,838
Common stock warrants		285,655		-
Options		354,951		337,500
Total		1,381,007		3,103,380

Stock Based Compensation

9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Based Compensation

Stock Based Compensation

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Following stockholder approval of the 2014 Plan, the Company will no longer grant equity awards under the 2007 Plan. Stock-based compensation expense for the three months ended September 30, 2014 and 2013 was $178 and $0, respectively. Stock-based compensation expense for the nine months ended September 30, 2014 and 2013 was $178 and $141, respectively. As of September 30, 2014, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 450,000 shares of an aggregate total of 450,000 shares were available for future stock-based compensation grants under the 2014 Plan.

The Company accounts for its employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. All stock option grants have an exercise price equal to the fair market value of the Company’s common stock on the date of grant and generally have a 10-year term. The fair value of stock option grants is amortized to expense over the vesting period. The grant date fair value of the 2014 stock options granted under the 2007 Plan were immediately expensed as the options were fully vested upon the grant date.

The Company’s weighted-average Black-Scholes fair value assumptions for 2014 are as follows:

	2014
Expected Life in years		5
Risk free interest rate		1.67	%
Expected volatility		82.8	%
Expected dividend yield		0.0	%

The expected life is the period over which its employee groups are expected to hold their options. The risk-free interest rate is based on the expected U.S. Treasury rate at the time of grant. Volatility reflects movements in the stock price of comparable companies over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy.

A summary of the Company’s stock-based compensation activity for the nine months ended September 30, 2014 is presented below:

				Weighted Average
	Options			Exercise Price		Remaining Contractual Term (in years)		Intrinsic Value
Outstanding at December 31, 2013		337,500		$	0.52
Granted		70,000		$	3.85
Exercised		(1,200	)	$	0.52
Forfeited/expired		-		$	-
Outstanding and Exercisable at September 30, 2014		406,300		$	1.09		6.17	$	844,113

As of September 30, 2014, there was $0 of total unrecognized compensation cost related to non-vested share-based compensation grants. There were no share-based compensation grants in 2013.

Assets for Lease (Tables)

9 Months Ended

Sep. 30, 2014

Leases, Capital [Abstract]

Schedule of assets for lease

	September 30, 2014			December 31, 2013

Assets for lease	$	943		$	688
Less: Accumulated Depreciation		(247	)		(176	)
Assets for lease, net	$	696		$	512

Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2014

Accrued Liabilities, Current [Abstract]

Schedule of accrued expenses

	September 30, 2014		December 31, 2013

Offering Costs	$	497	$	722
Compensation		589		264
Miscellaneous Accruals		386		142
Total Accrued Expenses	$	1,472	$	1,128

Net Loss Per Common Share (Tables)

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Schedule of common stock equivalents excluded from the computation of diluted net loss per share

	Three Months ended September 30,
	2014		2013
Weighted average shares outstanding:
Convertible preferred stock		-		1,480,042
Convertible preferred stock warrants		-		1,285,838
Common stock warrants		359,714		-
Options		389,663		337,500
Total		749,377		3,103,380

	Nine Months ended September 30,
	2014		2013
Weighted average shares outstanding:
Convertible preferred stock		414,267		1,480,042
Convertible preferred stock warrants		326,134		1,285,838
Common stock warrants		285,655		-
Options		354,951		337,500
Total		1,381,007		3,103,380

Stock Based Compensation (Tables)

9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of weighted-average Black-Scholes fair value assumptions

	2014
Expected Life in years		5
Risk free interest rate		1.67	%
Expected volatility		82.8	%
Expected dividend yield		0.0	%

Schedule of summary of stock-based compensation activity

				Weighted Average
	Options			Exercise Price		Remaining Contractual Term (in years)		Intrinsic Value
Outstanding at December 31, 2013		337,500		$	0.52
Granted		70,000		$	3.85
Exercised		(1,200	)	$	0.52
Forfeited/expired		-		$	-
Outstanding and Exercisable at September 30, 2014		406,300		$	1.09		6.17	$	844,113

Basis of Presentation (Detail Textuals) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	Feb. 28, 2014	Mar. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
Initial public offering
Basis Of Presentation [Line Items]
Number of common stock shares issued	1,430,000
Public offering price per share	$ 7.00
Net proceeds from initial public offering	$ 7,403
Underwriting discounts and commissions	848
Other offering expenses	$ 1,759
Offering expenses		$ 1,959		$ 648
Initial public offering \| Series A Preferred Stock
Basis Of Presentation [Line Items]
Number of common stock called by warrants			1,067,210
Number of preferred stocks shares converted			1,468,402
Initial public offering \| Series A-1 Preferred Stock
Basis Of Presentation [Line Items]
Number of common stock called by warrants			228,656
Number of preferred stocks shares converted			293,750
Initial public offering \| Series A-2 Preferred Stock
Basis Of Presentation [Line Items]
Number of preferred stocks shares converted			250,000
Initial public offering \| Common Stock
Basis Of Presentation [Line Items]
Number of shares issued for conversion of preferred stock			2,012,152
Aggregate number of common stock shares exercisable at initial public offering			479,115
Over allotment option
Basis Of Presentation [Line Items]
Number of common stock shares issued			214,500
Number of common stock called by warrants			71,500
Exercise price per warrants			$ 8.75

Assets for Lease - Summary of assets for lease (Details) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Leases, Capital [Abstract]
Assets for lease	$ 943	$ 688
Less: Accumulated Depreciation	(247)	(176)
Assets for lease, net	$ 696	$ 512

Assets for Lease (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Assets for Lease (Detail Textuals) - USD ($) $ in Thousands	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Leases, Capital [Abstract]
Depreciation expense	$ 48	$ 35	$ 140	$ 86
Reduction to accumulated depreciation for returned items	$ 21	$ 21	$ 69	$ 27

Deferred Financing Costs (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Deferred Finance Costs [Abstract]
Deferred financing costs	$ 73		$ 73		$ 202
Amortized interest expense	$ 85	$ 22	$ 129	$ 66

Accrued Expenses - Summary of accrued expenses (Details) - USD ($) $ in Thousands	Sep. 30, 2014	Dec. 31, 2013
Accrued Liabilities, Current [Abstract]
Offering Costs	$ 497	$ 722
Compensation	589	264
Miscellaneous Accruals	386	142
Total Accrued Expenses	$ 1,472	$ 1,128

Commitments and Contingencies (Detail Textuals) - Secured Debt - USD ($) $ in Thousands			1 Months Ended		9 Months Ended	12 Months Ended
	Sep. 13, 2011	Feb. 09, 2011	Jun. 17, 2011	May 27, 2011	Sep. 30, 2014	Dec. 31, 2011	Dec. 31, 2013
Equipment Finance Agreement \| U.S. Bancorp Business Equipment Finance Group
Commitments And Contingencies [Line Items]
Amount of secured loan obtained		$ 39		$ 109
Term of secured loan		48 months		60 months
Annual fixed interest rate		13.00%		6.00%
Monthly principal payment		$ 1		$ 2
Frequency of payment		Monthly		Monthly
Amount of outstanding borrowings							$ 13
Equipment Finance Agreement \| U.S. Bancorp Business Equipment Finance Group
Commitments And Contingencies [Line Items]
Amount of outstanding borrowings							57
Lease Agreements \| Lease Corporation of America
Commitments And Contingencies [Line Items]
Amount of secured loan obtained						$ 66
Term of secured loan						60 months
Annual fixed interest rate						14.00%
Monthly principal payment						$ 1
Frequency of payment						Monthly
Amount of outstanding borrowings							42
Loan Agreement \| First Republic Bank
Commitments And Contingencies [Line Items]
Amount of secured loan obtained			$ 150
Term of secured loan			60 months
Annual variable interest rate			1.75%
Floor interest rate on loan			3.25%
Description of interest rates			Prime rate
Annual fixed interest rate			5.00%
Monthly principal payment			$ 3
Frequency of payment			Monthly
Amount of outstanding borrowings							75
Additional Loan Agreements \| First Republic Bank
Commitments And Contingencies [Line Items]
Amount of secured loan obtained	$ 150
Term of secured loan	60 months
Annual variable interest rate	1.75%
Floor interest rate on loan	3.25%
Description of interest rates	Prime rate
Annual fixed interest rate	5.00%
Monthly principal payment	$ 3
Frequency of payment	Monthly
Amount of outstanding borrowings							$ 83
Line Of Credit Agreement \| First Republic Bank \| Revolving Credit Facility
Commitments And Contingencies [Line Items]
Maximum limit of borrowing					$ 2,000
Term of secured loan					12 months
Floor interest rate on loan					2.00%
Description of interest rates					Prime rate
Annual fixed interest rate					1.25%
Monthly principal payment					$ 2,002
Monthly interest payment					$ 2
Frequency of payment					Monthly
Amount of outstanding borrowings					$ 113

Net Loss Per Common Share - Summary of outstanding shares of common stock equivalents excluded from the computation of diluted net loss per share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Weighted average shares outstanding:
Total	749,377	3,103,380	1,381,007	3,103,380
Convertible preferred stock
Weighted average shares outstanding:
Total		1,480,042	414,267	1,480,042
Convertible preferred stock warrants
Weighted average shares outstanding:
Total		1,285,838	326,134	1,285,838
Common stock warrants
Weighted average shares outstanding:
Total	359,714		285,655
Options
Weighted average shares outstanding:
Total	389,663	337,500	354,951	337,500

Stock Based Compensation - Weighted-average Black-Scholes fair value assumptions (Details)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected Life in years	5 years
Risk free interest rate	1.67%
Expected volatility	82.80%
Expected dividend yield	0.00%

Stock Based Compensation - Summary of stock-based compensation activity (Details 1)	9 Months Ended
	Sep. 30, 2014 USD ($) $ / shares shares
Options
Outstanding at December 31, 2013 \| shares	337,500
Granted \| shares	70,000
Exercised \| shares	(1,200)
Forfeited/expired \| shares
Outstanding and Exercisable at September 30, 2014 \| shares	406,300
Weighted Average Exercise Price
Outstanding at December 31, 2013 \| $ / shares	$ 0.52
Granted \| $ / shares	3.85
Exercised \| $ / shares	0.52
Forfeited/expired \| $ / shares
Outstanding and Exercisable at September 30, 2014 \| $ / shares	$ 1.09
Weighted Average Remaining Contractual Term (in years)	6 years 2 months 1 day
Intrinsic Value \| $	$ 844,113

Stock Based Compensation (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 178	$ 0	$ 178	$ 141
Total unrecognized compensation cost related to non-vested awards	$ 0		$ 0
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of stock option grants			10 years
Fair value method			Black-Scholes valuation model
2007 Key Person Stock Option Plan \| Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future stock-based compensation grants	0		0
Aggregate number of shares	407,500		407,500
2014 Stock Incentive Plan \| Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future stock-based compensation grants	450,000		450,000
Aggregate number of shares	450,000		450,000